Oracle (NYSE: ORCL) shares declined sharply on November 2 after the cloud infrastructure company filed plans to raise $20 bn in additional financing to support its artificial intelligence expansion.
The company intends to issue $10 bn in common stock alongside $10 bn in senior unsecured notes. The proceeds may fund capital expenditure, debt repayments, acquisitions and other corporate requirements.
- Oracle plans to raise $20 bn through stock and bond offerings, including $10 bn in common shares and $10 bn in senior notes. Shares fell nearly 5% on November 2 as investors assessed dilution and rising financing costs.
- Oracle’s debt reached $125.34 bn as of August 31, while its five-year credit default swap spread climbed to approximately 296 basis points. S&P rates the company BBB-, its lowest investment-grade category.
- Wall Street remains divided on Oracle’s valuation. Bank of America maintains a $240 price target, Goldman Sachs targets $206, JPMorgan $200 and Morgan Stanley $210. The company’s ability to generate positive free cash flow will be critical to its share price recovery.
Oracle shares traded at approximately $124.57, down 4.7%, during Monday morning trading. The stock had already declined about 33% in 2026, reflecting mounting concerns about the financial sustainability of its AI investments.
The latest financing announcement came just five days after Oracle presented ambitious revenue and cash flow forecasts at its October 28 investor day.
Management expects annual revenue to exceed $225 bn by fiscal 2030, compared with $67.36 bn in fiscal 2026.
However, investors are increasingly questioning how much additional borrowing and shareholder dilution will be required before those revenue projections translate into sustainable free cash flow.
Why Oracle shares fell after the $20 bn financing announcement
Oracle’s financing plan consists of two separate transactions. The first is a proposed $10 bn common stock offering. The second involves $10 bn in senior notes with maturities extending from 2029 through 2046.
According to the company’s preliminary prospectus, the stock offering would involve approximately 76.5 mn shares if priced at the October 30 closing price of $130.67.
That would represent roughly 2.5% additional shares relative to the approximately 3.02 bn outstanding before the transaction.
Actual dilution will depend on the final offering price. The debt offering introduces another financial obligation at a time when Oracle’s borrowing costs have increased substantially.
The financing transactions have not necessarily been completed, and final pricing remains subject to market conditions.
Importantly, Oracle had already completed a separate $20 bn at-the-market equity raise in fiscal Q1 2027.
The latest $20 bn financing plan is additional to that earlier capital raise, although Oracle has committed to limiting further capital-market funding through fiscal 2030, excluding debt refinancing.
For existing shareholders, the concern is whether future earnings growth will be sufficient to compensate for the additional equity issued and financing costs incurred.
Oracle’s debt and credit default swaps signal rising financial pressure
Oracle reported approximately $125.34 bn in notes payable and other borrowings as of August 31, 2026. That compares with annual revenue of $67.36 bn in fiscal 2026. The company’s debt burden has become one of the principal factors influencing investor sentiment.
Oracle’s five-year credit default swap spread reached approximately 296 basis points on November 2, indicating that investors are demanding greater compensation for credit exposure.
The spread has increased substantially over the past year. Meanwhile, the yield on Oracle’s existing 4.95% bond maturing in 2031 reached approximately 7.16%. These figures indicate that Oracle faces significantly higher financing costs than during the earlier stages of its AI expansion.
S&P Global Ratings downgraded Oracle to BBB- in July, placing the company just one rating level above speculative grade.
Research from LSEG shows that Oracle’s bonds trade at substantially wider credit spreads than those issued by Microsoft, Alphabet and Amazon.
As of October 21, Oracle’s five-year CDS spread was approximately 331 basis points, compared with 80 basis points for Amazon and 56 basis points for Microsoft. LSEG
Oracle remains investment grade, and a wider CDS spread does not establish that default is likely.
However, another credit rating downgrade could increase borrowing costs and reduce demand from institutional investors operating under investment-grade investment restrictions.
That could make Oracle’s AI expansion more expensive to finance.
Wall Street analysts maintain significant upside targets for ORCL
Despite the stock’s decline, several investment banks continue to forecast a substantial recovery in Oracle’s share price.
- Bank of America Securities analyst Tal Liani reiterated a Buy rating and $240 price target on October 30.
- Goldman Sachs maintained a Buy rating with a $206 target following an October revision.
- JPMorgan maintained an Overweight-equivalent bullish position, with a reported $200 price target.
- Morgan Stanley maintained a more cautious Equal-Weight rating and $210 target.
Other institutional forecasts include:
- UBS: $250
- Barclays: $252
- Wells Fargo: $250
- BMO Capital Markets: $195
- Bernstein: $325
- RBC Capital Markets: $165
These forecasts were published before the November 2 financing announcement or shortly after the October investor day. They may change as analysts incorporate the final offering terms and updated financing costs.
At an intraday price of approximately $124.57, even the more conservative major-bank targets suggest substantial potential upside. However, the gap between current valuations and analyst forecasts reflects considerable uncertainty about the timing and profitability of Oracle’s AI infrastructure investments.
The stock’s recovery will depend on whether the company can deliver its projected earnings growth while limiting further increases in debt.
Oracle forecasts $225 bn in revenue by fiscal 2030
At its October 28 investor day, Oracle outlined an aggressive growth strategy extending through fiscal 2030.
Management expects:
- Fiscal 2027 revenue of at least $90 bn.
- Fiscal 2027 adjusted EPS of $8.10.
- Fiscal 2030 revenue of at least $225 bn.
- Fiscal 2030 adjusted EPS exceeding $21.
- Fiscal 2030 non-GAAP operating margin above 40%.
- Positive free cash flow during H2 fiscal 2028.
- Annual free cash flow exceeding $30 bn in fiscal 2029.
The revenue outlook implies compound annual growth exceeding 35% between fiscal 2026 and fiscal 2030. Oracle expects capital expenditure to peak during fiscal 2027 and fiscal 2028 before declining as its data center expansion progresses.
Management also expects customer prepayments, vendor financing and customer-provided hardware to reduce upfront capital requirements.
The central question is whether Oracle can convert its contracted cloud demand into revenue quickly enough to support the investment required. Strong revenue growth alone may not be sufficient to restore investor confidence if capital expenditure and interest costs continue absorbing operating cash flow.
Can Oracle’s AI partnerships support its valuation?
Oracle has expanded its AI ecosystem through relationships with OpenAI, Nvidia, Google, Intel, Snowflake and other technology companies. These partnerships support demand for Oracle Cloud Infrastructure and reinforce its position as an alternative to Amazon Web Services, Microsoft Azure and Google Cloud. However, Oracle’s business model involves significant upfront expenditure.
New data centers require substantial investment in computing equipment, networking infrastructure, energy capacity and supporting facilities. The company must incur many of these costs before the related customer contracts generate their full revenue potential.
Oracle also has greater financial exposure to individual AI customers than some larger cloud competitors. That concentration increases the importance of customer credit quality, contractual commitments and the commercial success of AI services.
If demand remains strong and contracts convert into cash flow as planned, Oracle could experience substantial operating leverage.
Is Oracle stock undervalued after its 2026 decline?
A widely circulated valuation estimate places Oracle’s fair value at approximately $192.59 per share.
Against its October 30 closing price of $130.67, that represents a discount of approximately 32%. However, this is an independent investor valuation model, not a price target issued by an investment bank. Its reliability depends on assumptions about revenue growth, profitability, capital expenditure, financing costs and the discount rate applied to future cash flows.
Oracle’s valuation is particularly sensitive to the timing of its expected free cash flow recovery.
- If capital expenditure falls as planned and free cash flow exceeds $30 bn in fiscal 2029, the company’s current valuation could become considerably more attractive.
- If those milestones are delayed, Oracle could continue trading below historical valuation levels despite substantial revenue growth.
The stock’s decline therefore cannot be assessed solely by comparing its current price with previous highs.
Investors must also consider changes in its capital structure and the financial risks associated with the AI buildout.
Oracle stock price forecast for 2027
Based on current valuations, investment bank targets, projected earnings growth and Oracle’s financing requirements, Beinsure identifies three conditional scenarios for the next 12 months.
These are independent analytical scenarios, not official bank forecasts.
Bearish forecast: $90-$120
The bearish scenario assumes that Oracle’s capital expenditure remains elevated longer than anticipated. Higher borrowing costs, weaker cloud margins or slower contract monetization could delay positive free cash flow. Additional pressure on credit ratings would increase financial uncertainty.
Under these conditions, ORCL could remain below $120 and potentially decline toward $90 if investors demand a larger discount for balance-sheet risk.
Base forecast: $140-$185
The base scenario assumes that Oracle maintains strong cloud revenue growth and demonstrates progress toward its fiscal 2028 free cash flow target.
Capital expenditure remains substantial but begins stabilizing as new infrastructure becomes operational. Credit conditions do not deteriorate materially, and management avoids additional unexpected financing requirements.
Under these assumptions, Oracle shares could recover toward $140-$185 over the next 12 months.
Bullish forecast: $200-$250
The bullish scenario assumes accelerating cloud revenue, stronger operating margins and improving confidence in Oracle’s financial projections.
Investors gain evidence that infrastructure spending will decline as planned and that operating cash flow can cover future investment requirements. Lower credit spreads could also reduce concerns about borrowing costs.
In this scenario, Oracle could recover toward $200-$250, broadly consistent with several existing investment bank price targets.
What will determine Oracle’s share price next?
Oracle’s immediate outlook depends on three financial developments.
- First, investors will assess the final terms of the $20 bn capital raise, including the number of shares issued and interest rates on the new bonds.
- Second, future earnings reports will need to demonstrate that cloud infrastructure revenue is growing sufficiently to support Oracle’s ambitious fiscal 2030 targets.
- Third, the market will monitor whether Oracle can preserve its investment-grade credit rating and achieve positive free cash flow during fiscal 2028.
The company has outlined a credible path to substantial revenue expansion, but its balance sheet has become a major constraint on investor confidence.
Oracle’s stock valuation now depends as much on financing costs and cash generation as on demand for artificial intelligence infrastructure.
The November 2 selloff indicates that investors want stronger evidence that the company’s AI investments can deliver returns without requiring continued increases in debt and shareholder dilution.
Oracle’s longer-term growth prospects remain substantial. The near-term risk is that the cost of financing that growth continues to rise before its financial benefits become visible.
